Seminars in Diagnostic Pathology
Volume 23, Issue 2 , Pages 120-129, May 2006

Occurrence of other malignancies in patients with gastrointestinal stromal tumors

  • Abbas Agaimy, MD

      Affiliations

    • Institute of Pathology, Nuremberg Clinic Center, Nuremberg, Germany
    • Corresponding Author InformationAddress reprint requests and correspondence: Abbas Agaimy, MD, Institute of Pathology, Nuremberg Clinic Center, Prof.-Ernst-Nathan-Strasse 1, 90419 Nuremberg, Germany.
  • ,
  • Peter H. Wünsch, MD

      Affiliations

    • Institute of Pathology, Nuremberg Clinic Center, Nuremberg, Germany
  • ,
  • Leslie H. Sobin, MD

      Affiliations

    • Department of Hepatic and Gastrointestinal Pathology, Armed Forces Institute of Pathology, Washington, DC
  • ,
  • Jerzy Lasota, MD

      Affiliations

    • Department of Soft Tissue Pathology, Armed Forces Institute of Pathology, Washington, DC.
  • ,
  • Markku Miettinen, MD

      Affiliations

    • Department of Soft Tissue Pathology, Armed Forces Institute of Pathology, Washington, DC.

Almost one-third of gastrointestinal stromal tumors (GISTs) are discovered incidentally during investigative or therapeutic procedures for unrelated diseases. In this regard, GISTs may coexist with different types of cancer, either synchronously or metachronously. The frequency of this association and the spectrum of neoplasms involved have not been sufficiently analyzed. We conducted a review of the literature and our own records for cases with sporadic GISTs and other malignancies, with emphasis on solid tumors. Neurofibromatosis 1 and Carney triad-associated tumors were excluded. Based on these data, there were 518 cancers in 486 GIST patients among 4813 cases with informative data. The overall frequency of second tumors in different series varied from 4.5% to 33% (mean, 13%). A total of 29 patients had multiple malignancies. GISTs of gastric location were most commonly involved with other neoplasms, reflecting their overall high frequency (60%) of all GISTs. The major types of GIST-associated cancers were gastrointestinal carcinomas (n = 228; 47%), lymphoma/leukemia, (n = 36; 7%), and carcinomas of prostate (n = 43; 9%), breast (n = 34; 7%), kidney (n = 27; 6%), lung (n = 26; 5%), female genital tract (n = 25; 5%), and carcinoid tumors (n = 13; 3%). Other cancers included soft tissue and bone sarcomas (n = 15; 3%), malignant melanoma (n = 12; 2%), and seminoma (n = 6; 1%). Occurrence of collision tumors and metastases of carcinoma or sarcoma into a GIST (the latter noted in 4 cases) can be challenging diagnostic problems. The potential nonrandom association and causal relationship between GIST and other neoplasms remain to be investigated.

Keywords: GIST, Gastrointestinal cancer, Coincidence, Carcinoma, Sarcoma, Melanoma, Seminoma, Lymphoma, Multiple cancers

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0740-2570(06)00146-8

doi:10.1053/j.semdp.2006.09.004

Seminars in Diagnostic Pathology
Volume 23, Issue 2 , Pages 120-129, May 2006